LOY-002

Asset

Improves metabolic health by increasing insulin sensitivity and lowering insulin levels.

Stage: Veterinary
Modality: Small molecule
Target: Lipid and ceramide metabolism; 1
Indication: 0
Trials: 1
Developer

Indications

1

Lifespan in senior dogs
Veterinary, loyal.com, 8 Oct 2026

In the full profile

Targets and what it contains2
Owner and partners1
Evidence for its targets3
Competitors2
Aging relevance1
Signals2

Every asset’s record: target, stage, trials and the evidence behind it.